Gufic Biosciences Ltd vs Vista Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 11, 2026

Key Highlights

The Latest Trading Price of Gufic BioSciences Ltd is ₹ 354 as of 11 Jun 15:30 . The P/E Ratio of Gufic BioSciences Ltd is 33 as of March 2024 .The P/E Ratio of Vista Pharmaceuticals Ltd is 0 as of March 2024 . The Market Cap of Gufic BioSciences Ltd is ₹ 2839 crore as of March 2024 .The Market Cap of Vista Pharmaceuticals Ltd is ₹ 0 crore as of March 2024 . The revenue of Gufic BioSciences Ltd for the Mar '26 is ₹ 250.65 crore as compare to the Dec '25 revenue of ₹ 232.2 crore. This represent the growth of 7.95% The revenue of Vista Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Gufic BioSciences Ltd for the Mar '26 is ₹ 46.04 crore as compare to the Dec '25 ebitda of ₹ 33.77 crore. This represent the growth of 36.33% The ebitda of Vista Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Gufic BioSciences Ltd changed from ₹ 20.86 crore to ₹ 21.9 crore over 8 quarters. This represents a CAGR of 2.46% The net profit of Vista Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Gufic BioSciences Ltd changed from 2.19 % on March 2021 to 1.43 % on March 2025 . This represents a CAGR of -8.17% over 5 yearsThe Dividend Payout of Vista Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Gufic BioSciences Ltd

Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients.
Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network.
The Company is ranked among the top 100 pharmaceutical companies in India. Gufic is a leading manufacturer of lyophilized injections in India, with a state-of-the-art automated lyophilization plant located in Navsari, Gujarat.
The Company was incorporated in July, 1984.
The recent addition of the Indore manufacturing facility has further solidified Gufic's position as one of the world's largest producers of lyophilized injections.

About Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & had obtained Certificate of Commencement of Business on February 7, 1991.
The Company is engaged in the formulation of pharmaceutical products.
It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments.
This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India. The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.
Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.

FAQs for the comparison of Gufic BioSciences Ltd and Vista Pharmaceuticals Ltd

Which company has a larger market capitalization, Gufic BioSciences Ltd or Vista Pharmaceuticals Ltd?

Market cap of Gufic BioSciences Ltd is 3,550 Cr while Market cap of Vista Pharmaceuticals Ltd is 43 Cr

What are the key factors driving the stock performance of Gufic BioSciences Ltd and Vista Pharmaceuticals Ltd?

The stock performance of Gufic BioSciences Ltd and Vista Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gufic BioSciences Ltd and Vista Pharmaceuticals Ltd?

As of June 11, 2026, the Gufic BioSciences Ltd stock price is INR ₹354.0. On the other hand, Vista Pharmaceuticals Ltd stock price is INR ₹7.1.

How do dividend payouts of Gufic BioSciences Ltd and Vista Pharmaceuticals Ltd compare?

To compare the dividend payouts of Gufic BioSciences Ltd and Vista Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.